From Republika Online · · 1m 10s
UBSI and International Partners Discuss AI for Drug Research
UBSI partners with global institutions to use AI and supercomputers for natural product drug research.
In brief
UBSI partners with global institutions to use AI and supercomputers for natural product drug research. UBSI collaborates with BRIN, SIAT, NTU Singapore, and Aptikom to apply AI and supercomputing for natural product drug screening. Originally reported by Republika Online.
International Research Collaboration
UBSI hosts a research event with BRIN, SIAT, NTU Singapore, and Aptikom to discuss AI and supercomputing for drug development.
Event Theme and Purpose
The event focuses on artificial intelligence and privacy computing for natural product drug screening to address health research challenges.
Key Participants
Assoc. Prof. Dr. Diah Puspitasari and Prof. Dr. Didi Rosiyadi lead discussions on AI and privacy computing for natural product research.
AI and Supercomputing Applications
AI and high-performance computing enable large-scale analysis of natural products for drug development while maintaining data privacy.
Research Collaboration Goals
UBSI aims to integrate AI with natural product research to create globally impactful health and technology solutions.
Event Outcome
The collaboration strengthens international research networks for drug development using AI and privacy computing technologies.
Here's the gist
UBSI collaborates with BRIN, SIAT, NTU Singapore, and Aptikom to apply AI and supercomputing for natural product drug screening.
